1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Parallel, Multi-Center, Double-masked, Active controlled, three arm study comparing the IOP
lowering efficacy and safety over 12 months of morning or evening instillations of
Travoprost/Brinzolamide vs. Cosopt dosed in the morning and evening in patients with
open-angle glaucoma or ocular hypertension.